文献速递冠心病外科心外重症与机械循环支持

愿意考虑HCV阳性供心的获益:注册登记分析

For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-06-28

基于2018年至2023年3月器官共享联合网络登记数据,在19,415名成人心脏移植等待者中,68.9%愿意考虑HCV阳性供心。调整协变量及中心聚集效应后,愿意考虑者等待期死亡风险降低37%(SHR 0.63,95%CI 0.56-0.70,P<.001),接受移植可能性高21%(SHR 1.21,95%CI 1.7-1.26,P<.001)。

要点

  • 愿意考虑HCV阳性供心者等待期死亡风险显著低于不愿意者(SHR 0.63)。
  • 愿意考虑者接受移植可能性显著高于不愿意者(SHR 1.21)。
  • 在临时及持久机械循环支持亚组中同样观察到等待期死亡率降低。

核心结论

  • 愿意考虑HCV阳性供心与等待期死亡风险降低37%及接受移植可能性升高21%相关。

研究设计与样本

  • 基于器官共享联合网络(Scientific Registry of Transplant Recipients)的登记数据分析。
  • 纳入2018年至2023年3月期间在等待名单上的成人(年龄≥18岁)心脏移植候选者,共19,415人。
  • 采用竞争风险回归比较愿意与不愿意考虑HCV阳性供心者的等待期死亡或心脏移植可能性。

主要发现

  • 19,415名候选者中68.9%愿意考虑HCV阳性供心。
  • 调整协变量及中心水平聚集后,愿意考虑者等待期死亡风险较不愿意者降低37%(SHR 0.63;95%CI 0.56-0.70;P<.001)。
  • 愿意考虑者接受移植可能性较不愿意者高21%(SHR 1.21;95%CI 1.7-1.26;P<.001)。
  • 3年后愿意考虑者中74.9%接受移植、6.1%死亡/恶化,不愿意者分别为68.3%和9.1%。
  • 在临时及持久机械循环支持候选者亚组分析中亦观察到等待期死亡率降低。

临床怎么用

  • 鼓励候选者登记为愿意考虑丙型肝炎供者供心,以优化等待期结局和移植可及性。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite excellent outcomes of heart transplants from hepatitis C virus (HCV)-positive donors (D+), many candidates are not listed to even consider HCV D+ offers. METHODS: Using the Scientific Registry of Transplant Recipients, we identified adult (age ≥18 years) heart transplant candidates prevalent on the waitlist between 2018 and March 2023. We compared the likelihood of waitlist mortality or heart transplant by candidate willingness to consider HCV D+ offers using competing risk regression. RESULTS: We identified 19,415 heart transplant candidates, 68.9% of whom were willing to consider HCV D+ offers. Candidates willing to consider HCV D+ offers had a 37% lower risk of waitlist mortality (subhazard ratio [SHR], 0.63; 95% confidence interval [CI], 0.56-0.70; P < .001) than candidates not willing to consider HCV D+ offers, after adjustment for covariates and center-level clustering. Over the same period, heart transplant candidates willing to consider HCV D+ offers had a 21% higher likelihood of receiving a transplant (SHR, 1.21; 95% CI, 1.7-1.26; P < .001). As a result, among candidates willing to consider HCV D+ offers, 74.9% received a transplant and 6.1% died/deteriorated after 3 years, compared to 68.3% and 9.1%, respectively, of candidates not willing to consider HCV D+ offers. Lower waitlist mortality also was observed on subgroup analyses of candidates on temporary and durable mechanical circulatory support. CONCLUSIONS: Willingness to consider HCV D+ heart offers was associated with a 37% lower risk of waitlist mortality and a 21% higher likelihood of receiving a transplant. We urge providers to encourage candidates to list as being willing to consider offers from donors with hepatitis C to optimize their waitlist outcomes and access to transplantation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ruck JM, Rodriguez E, Zhou AL, et al. For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C. J Thorac Cardiovasc Surg. 2024. PMID: 38945356. doi:10.1016/j.jtcvs.2024.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。